Vitamin D-Binding Protein (DBP) Gene Polymorphism is Associated with Graves' Disease and the Vitamin D Status in a Polish Population Study

Abstract

Objective: Vitamin D-binding protein (DBP) genetic variants have an influence on vitamin D status and, therefore, they may contribute to the development of autoimmune diseases. In this case-control study, we investigated the association of DBP gene polymorphisms with susceptibility to Graves' disease (GD) in a Polish population. Furthermore, we analyzed the distribution of DBP genotypes in GD patients divided according to the clinical (gender, age of onset, ophthalmopathy, family history, smoking habits) and genetic parameters (CTLA4 49G and HLA-DRB1*03 alleles), as well as the vitamin D serum levels. Methods: 332 polish patients with GD and 185 healthy controls were genotyped for the DBP gene single nucleotide polymorphisms (SNPs) at codon 420 ACG → AAG (Thr → Lys) and at codon 416 GAT → GAG (Asp → Glu) by the PCR-RFLP method. The variable (TAAA)_N repeat polymorphism in the intron 8 was analyzed in 332 patients and 164 controls by the PCR amplification followed by the PAGE. In addition, 25(OH)D₃ serum levels were measured in 110 patients. Results: In patients with GD, the frequency of the Lys allele (34.2 % vs. 25.7 %, p = 0.005; OR = 1.50; 95 % CI: 1.13 - 1.99) at codon 420 was significantly higher compared to controls. The distribution of codon 420 genotypes also differed significantly (p = 0.01), with the frequency of the Lys/Lys homozygotes (9.3 % vs. 5.9 %; OR = 1.63; 95 % CI: 0.80 - 3.32) being higher in GD. The distribution of codon 416 alleles and genotypes did not differ in both studied groups (p = 0.59 and p = 0.81, respectively). Analysis of the intron 8 (TAAA)_N repeat polymorphism led to the identification of a novel variant in the Polish population, described as 7 repeats, but no association between the intron 8 alleles and GD was observed. The 420 Lys allele was associated with lower 25(OH)D₃ serum levels (p = 0.01). No correlation between the DBP genotypes and other susceptibility alleles or the GD clinical phenotype was observed. Conclusions: (i) The DBP gene Lys allele at codon 420 confers susceptibility to GD in the Polish population, (ii) the codon 416 alleles and intron 8 (TAAA)_N variants are not associated with susceptibility to and clinical phenotype of GD, and (iii) the codon 420 Lys allele correlates with lower 25(OH)D₃ serum concentration.

Graves' disease (GD) - vitamin D - vitamin D-binding protein (DBP) - genetic polymorphism

References

• 1 Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP).  Hum Genet. 1993;  92 183-188
• 2 Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA‐4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.  Eur J Endocrinol. 2003;  148 13-18
• 3 Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.  Hum Immunol. 2004;  65 632-639
• 4 Deluca H F, Cantorna M T. Vitamin D: its role and uses in immunology.  FASEB J. 2001;  15 2579-2585
• 5 Di Bacco M, Luiselli D, Manca M L, Sicilaino G. Bayesian approach to searching for susceptibility genes Gc2 and EsD1 alleles and multiple sclerosis.  Coll Antropol. 2002;  26 77-84
• 6 Fournier C, Gepner P, Sadouk M, Charreire J. In vivo beneficial effects of cyclosporin A and 1, 25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis.  Clin Immunol Immunopathol. 1990;  54 53-63
• 7 Gomme P T, Bertolini J. Therapeutic potential of vitamin D-binding protein.  Trends Biotechnol. 2004;  22 340-345
• 8 Hedrick P W. Genetic disequilibrium measures: proceed with caution.  Genetics. 1987;  117 331-341
• 9 Klupa T, Malecki M T, Hanna L, Sieradzka J, Frey J, Warram J H, Sieradzki J, Krolewski A S. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin.  Eur J Endocrinol. 1999;  141 490-493
• 10 Malabanan A, Veronikis I E, Holick M F. Redefining vitamin D insufficiency.  Lancet. 1998;  351 805-806
• 11 Malecki M T, Klupa T, Wanic K, Cyganek K, Frey J, Sieradzki J. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population.  Diabetes Res Clin Pract. 2002;  57 99-104
• 12 Ogunkolade B-W, Boucher B J, Prahl J M, Bustin S A, Burrin J M, Noonan K, North B V, Mannan N, McDermott M F, DeLuca H F, Hitman G A. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians.  Diabetes. 2002;  51 2294-2300
• 13 Ongagna J C, Kaltenbacher M C, Sapin R, Pinget M, Belcourt A. The HLA‐DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in Alsace.  Clin Biochem. 2001;  34 59-63
• 14 Pani M A, Donner H, Herwig J, Usadel K H, Badenhoop K. Vitamin D binding protein alleles and susceptibility for type 1 diabetes in Germans.  Autoimmunity. 1999;  31 67-72
• 15 Pani M A, Regulla K, Segni M, Hofmann S, Hüfner M, Pasquino A M, Usadel K H, Badenhoop K. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis.  J Clin Endocrinol Metab. 2002;  87 2564-2567
• 16 Papiha S S, Allcroft L C, Kanan R M, Francis R M, Datta H K. Vitamin D-binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)(n)-Alu polymorphism in DBP.  Calcif Tissue Int. 1999;  65 262-266
• 17 Papiha S S, Pal B. Gc (vitamin D-binding protein) subtypes in rheumatoid arthritis.  Hum Genet. 1985;  70 278-280
• 18 Perneger T V. What's wrong with Bonferroni adjustments?.  BMJ. 1998;  7139 1236-1238
• 19 Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data.  Am J Hum Genet. 2003;  73 1162-1169
• 20 Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data.  Am J Hum Genet. 2001;  68 978-989
• 21 Tokuda N, Mano T, Levy R B. 1,25-Dihydroxyvitamin D3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular Leydig cells.  Endocrinology. 1990;  127 1419-1427
• 22 Tomer Y, Davies T F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function.  Endocr Rev. 2003;  24 694-717
• 23 White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein.  Trends Endocrinol Metab. 2000;  11 320-327
• 24 Woolf B. On estimating the relation between blood group and disease.  Ann Hum Genet. 1955;  19 251-253
• 25 Yamamoto N, Homma S, Haddad J G, Kowalski M A. Vitamin D3 binding protein required for in vitro activation of macrophages after dodecylglycerol treatment of mouse peritoneal cells.  Immunology. 1991;  74 420-424
• 26 Yamashita H, Noguchi S, Takatsu K, Koike E, Murakami T, Watanabe S, Uchino S, Yamashita H, Kawamoto H. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease.  Endocr J. 2001;  48 63-69
• 27 Ye W Z, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians.  Metabolism. 2001;  50 366-369
• 28 Zhang J, Kew R R. Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function.  J Biol Chem. 2004;  279 53282-53287